“Initiatives of this kind continue to reinforce opportunities for investment in the specialty’s future, with funding that supports grants, research consensus panels, registries, clinical trials and educational programming,” said John A Kaufman, chair of the SIR Foundation board of directors. “Our specialty’s hallmarks are investigation and innovation, and the impact that major corporate support has on the future of the specialty is transformational,” noted Kaufman, who is also a professor and Frederick S Keller Chair of Interventional Radiology at the Dotter Interventional Institute in Portland, USA.
“AngioDynamics has always shared the SIR Foundation’s passion for fueling innovation in patient care through research and education. Our company is committed to being a partner in patient care with interventional radiologists through our support of the SIR Foundation and its pursuit of new discoveries in minimally invasive treatments,” said Joseph DeVivo, Angiodynamics’ president and chief executive officer.
The Discovery Campaign was initially launched in 2007 with an SIR membership phase. In 2010, the campaign began outreach to the medical technology industry for support.